WT1 peptide vaccination for pediatric patients: phase I/II study.
Phase 1
- Conditions
- pediatric malignant tumor, hematological malignancy
- Registration Number
- JPRN-UMIN000013252
- Lead Sponsor
- Osaka University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1) active infectious diseases 2)Severe Complications, including Heart failure, Renal faiure, Hapatic failure, ileus, uncontrolable DM, and so on 3)Other severe problems unsuitable for this study active infectious diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The frequency of side effect. The effectivness
- Secondary Outcome Measures
Name Time Method WT1specific immunological reaction